GB0706167D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0706167D0
GB0706167D0 GBGB0706167.4A GB0706167A GB0706167D0 GB 0706167 D0 GB0706167 D0 GB 0706167D0 GB 0706167 A GB0706167 A GB 0706167A GB 0706167 D0 GB0706167 D0 GB 0706167D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0706167.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38050489&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0706167(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0706167.4A priority Critical patent/GB0706167D0/en
Publication of GB0706167D0 publication Critical patent/GB0706167D0/en
Priority to CL200800865A priority patent/CL2008000865A1/en
Priority to ARP080101269A priority patent/AR065864A1/en
Priority to PCT/EP2008/053601 priority patent/WO2008119721A1/en
Priority to PE2008000559A priority patent/PE20090553A1/en
Priority to TW097110899A priority patent/TW200901979A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
GBGB0706167.4A 2007-03-29 2007-03-29 Compounds Ceased GB0706167D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0706167.4A GB0706167D0 (en) 2007-03-29 2007-03-29 Compounds
CL200800865A CL2008000865A1 (en) 2007-03-29 2008-03-26 COMPOUNDS DERIVED FROM BENZIMIDAZOL-2-ONA; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A PSYCHOTIC DISORDER OR A COGNITIVE DETERIORATION.
ARP080101269A AR065864A1 (en) 2007-03-29 2008-03-27 COMPOSITE OF OXI-CICLOHEXIL-PIPERIDINIL-DIHIDRO-BENZIMIDAZOL-2-ONA PHARMACEUTICAL COMPOSITION THAT IS INCLUDED IN ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT AND INTERMEDIARY COMPOUNDS FOR PREPARATION
PCT/EP2008/053601 WO2008119721A1 (en) 2007-03-29 2008-03-27 Compounds which have activity at m1 receptor and their uses in medicine
PE2008000559A PE20090553A1 (en) 2007-03-29 2008-03-27 BENZHIMIDAZOLONE DERIVED COMPOUNDS THAT HAVE ACTIVITY IN THE M1 RECEPTOR
TW097110899A TW200901979A (en) 2007-03-29 2008-03-27 Compounds which have activity at M1receptor and their uses in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0706167.4A GB0706167D0 (en) 2007-03-29 2007-03-29 Compounds

Publications (1)

Publication Number Publication Date
GB0706167D0 true GB0706167D0 (en) 2007-05-09

Family

ID=38050489

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0706167.4A Ceased GB0706167D0 (en) 2007-03-29 2007-03-29 Compounds

Country Status (6)

Country Link
AR (1) AR065864A1 (en)
CL (1) CL2008000865A1 (en)
GB (1) GB0706167D0 (en)
PE (1) PE20090553A1 (en)
TW (1) TW200901979A (en)
WO (1) WO2008119721A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5209479B2 (en) 2005-09-30 2013-06-12 グラクソ グループ リミテッド Benzimidazolones having activity at the M1 receptor
JP5209481B2 (en) 2005-09-30 2013-06-12 グラクソ グループ リミテッド Compounds having activity at the M1 receptor and their use in medicine
DE602006019119D1 (en) 2005-09-30 2011-02-03 Glaxo Group Ltd COMPOUNDS WITH ACTIVITY AT THE M1 RECEPTOR AND THEIR USE IN MEDICINE
WO2009037294A1 (en) 2007-09-20 2009-03-26 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
GB0718415D0 (en) 2007-09-20 2007-10-31 Glaxo Group Ltd Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701127B2 (en) * 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
AU7478396A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine agonists
DE60013464T2 (en) * 1999-10-13 2005-09-15 Banyu Pharmaceutical Co., Ltd. SUBSTITUTED IMIDAZOLIN DERIVATIVES
EP1515722A4 (en) * 2002-06-17 2006-06-21 Merck & Co Inc Ophthalmic compositions for treating ocular hypertension
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605785D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
CL2008000865A1 (en) 2008-10-03
WO2008119721A1 (en) 2008-10-09
AR065864A1 (en) 2009-07-08
TW200901979A (en) 2009-01-16
PE20090553A1 (en) 2009-06-06

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0700112D0 (en) Compounds
GB0701956D0 (en) Compounds
GB0700283D0 (en) Compounds
GB0701968D0 (en) Compounds
GB0702976D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)